Merrimack Pharmaceuticals
MACK
#7783
Rank
ยฃ0.17 B
Marketcap
ยฃ11.67
Share price
0.00%
Change (1 day)
19.34%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Cash on Hand

Cash on Hand as of March 2024 : ยฃ0.18 Billion

According to Merrimack Pharmaceuticals's latest financial reports the company has ยฃ0.18 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merrimack Pharmaceuticals - Cash on Hand chart (from 2010 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31ยฃ14.81 M-7.79%
2022-12-31ยฃ16.06 M52.71%
2021-12-31ยฃ10.52 M2.17%
2020-12-31ยฃ10.29 M-18.55%
2019-12-31ยฃ12.64 M-77.48%
2018-12-31ยฃ56.15 M-18.78%
2017-12-31ยฃ69.13 M296.35%
2016-12-31ยฃ17.44 M-86.07%
2015-12-31ยฃ0.12 B57.22%
2014-12-31ยฃ79.66 M-15.33%
2013-12-31ยฃ94.08 M38.31%
2012-12-31ยฃ68.02 M109.57%
2011-12-31ยฃ32.46 M63.16%
2010-12-31ยฃ19.89 M-44.86%
2009-12-31ยฃ36.08 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ5.61 B 2,883.95%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ59.69 M-68.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.27 B 48.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ44.98 M-76.11%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.99 M-98.94%๐Ÿ‡บ๐Ÿ‡ธ USA